Status:
UNKNOWN
Tranexamic Acid and Head and Neck Surgery Patients
Lead Sponsor:
Taichung Veterans General Hospital
Conditions:
Head and Neck Neoplasms
Eligibility:
All Genders
20-80 years
Phase:
PHASE3
Brief Summary
Tranexamic acid belongs to fibrinolytic inhibitors. Several prospective randomized clinical trials have proved its effectiveness in reducing intra-operative and post-operative bleeding in orthopedic a...
Detailed Description
Otolaryngologists often use drainage tube after head and neck surgery to reduce hematoma or seroma formation. In addition, the duration of drainage tube placement is closely related to the length of h...
Eligibility Criteria
Inclusion
- head and neck neoplasm scheduled for operation
Exclusion
- allergy to tranexamic acid
- history of coagulation disorders
- under anti-coagulation therapy
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00308880
Start Date
March 1 2006
End Date
March 1 2007
Last Update
March 30 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taichung Veterans General Hospital
Taichung, Taiwan, 40705